[go: up one dir, main page]

FI901956A0 - Nya naftalenylalkyl-3h-1,2,3,5 -oxatiadiazol-2-oxider anvaendbara som antihyperglykemiska medel. - Google Patents

Nya naftalenylalkyl-3h-1,2,3,5 -oxatiadiazol-2-oxider anvaendbara som antihyperglykemiska medel.

Info

Publication number
FI901956A0
FI901956A0 FI901956A FI901956A FI901956A0 FI 901956 A0 FI901956 A0 FI 901956A0 FI 901956 A FI901956 A FI 901956A FI 901956 A FI901956 A FI 901956A FI 901956 A0 FI901956 A0 FI 901956A0
Authority
FI
Finland
Prior art keywords
oxatiadiazole
naphthalenylalkyl
antihyperglycemical
oxider
medel
Prior art date
Application number
FI901956A
Other languages
English (en)
Finnish (fi)
Inventor
Thomas Richard Alessi
Terence Martin Dolak
John Watson Ellingboe
Louis John Lombardo
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of FI901956A0 publication Critical patent/FI901956A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/02—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms not condensed with other rings
    • C07D291/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI901956A 1989-04-21 1990-04-19 Nya naftalenylalkyl-3h-1,2,3,5 -oxatiadiazol-2-oxider anvaendbara som antihyperglykemiska medel. FI901956A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/341,340 US4897405A (en) 1989-04-21 1989-04-21 Novel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents

Publications (1)

Publication Number Publication Date
FI901956A0 true FI901956A0 (fi) 1990-04-19

Family

ID=23337136

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901956A FI901956A0 (fi) 1989-04-21 1990-04-19 Nya naftalenylalkyl-3h-1,2,3,5 -oxatiadiazol-2-oxider anvaendbara som antihyperglykemiska medel.

Country Status (12)

Country Link
US (1) US4897405A (zh)
JP (1) JPH02292272A (zh)
KR (1) KR900016174A (zh)
CN (1) CN1046528A (zh)
CA (1) CA2015032A1 (zh)
DD (1) DD298925A5 (zh)
FI (1) FI901956A0 (zh)
HU (1) HUT54360A (zh)
IL (1) IL94068A0 (zh)
NO (1) NO901728L (zh)
PT (1) PT93812A (zh)
ZA (1) ZA903018B (zh)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4142956C2 (de) * 1991-12-24 1996-08-14 Du Pont Deutschland Bleichbares Lichthofschutzsystem für photographische Aufzeichnungsmaterialien
US5874454A (en) * 1993-09-15 1999-02-23 Warner-Lambert Company Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US6046222A (en) * 1993-09-15 2000-04-04 Warner-Lambert Company Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
EP1714652A3 (en) * 1993-09-15 2007-01-17 Sankyo Company, Limited Use of thiazolidinediones to prevent or delay onset of niddm
US5399588A (en) * 1993-12-14 1995-03-21 American Home Products Corporation Naphthalenylmethyl cycloalkenone acetic acids and analogs thereof useful as aldose reductase inhibitors
US5444086A (en) * 1994-03-31 1995-08-22 American Home Products Corporation Naphthalenylmethyl thiophenones as antihyperglycemic agents
US5597826A (en) 1994-09-14 1997-01-28 Pfizer Inc. Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
US5708012A (en) * 1995-04-28 1998-01-13 Sankyo Company, Limited Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus
HUP9601808A3 (en) * 1995-07-03 2000-06-28 Sankyo Co Treatment of arteriosclerosis and xanthoma
BR9610207A (pt) * 1995-08-28 1999-02-02 American Home Prod Acidos fenóxi acéticos como inibidores da aldose redutase e agentes anti-hiperglicêmicos
AU7604596A (en) * 1995-11-17 1997-06-11 Warner-Lambert Company A method of treating myotonic dystrophy
CA2257284C (en) * 1996-05-31 2005-10-04 Sankyo Company Limited Remedy for autoimmune diseases
JP2001514663A (ja) * 1997-03-12 2001-09-11 エスモンド，ロバート ダブリュー． アルツハイマー病を処置または予防するための方法
HUP9902721A2 (hu) 1997-11-25 1999-12-28 The Procter & Gamble Co. Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület
US20040058873A1 (en) * 1998-03-12 2004-03-25 Esmond Robert W. Method for treating or preventing Alzheimer's disease
WO2000030628A2 (en) * 1998-11-20 2000-06-02 Genentech, Inc. Method of inhibiting angiogenesis
US6191154B1 (en) 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
WO2001077076A1 (fr) * 1999-06-02 2001-10-18 Torii Pharmaceutical Co., Ltd. Nouveaux derives de naphtalene
JP2001072592A (ja) 1999-07-01 2001-03-21 Kyowa Hakko Kogyo Co Ltd テロメラーゼ阻害剤
US6958355B2 (en) * 2000-04-24 2005-10-25 Aryx Therapeutics, Inc. Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6680387B2 (en) * 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
AU2001294673A1 (en) * 2000-09-21 2002-04-02 Aryx Therapeutics Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, andatherosclerosis
US6452014B1 (en) 2000-12-22 2002-09-17 Geron Corporation Telomerase inhibitors and methods of their use
US20060047000A1 (en) * 2001-04-24 2006-03-02 Aryx Therapeutics, Inc. Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US20070269486A1 (en) * 2005-03-14 2007-11-22 Conor Medsystems, Llc. Methods and Devices for Reducing Tissue Damage After Ischemic Injury
ES2385114T3 (es) 2007-03-30 2012-07-18 Ambrx, Inc. Polipéptidos de FGF-21 modificados y sus usos
EP2296664A1 (en) * 2008-04-15 2011-03-23 Burnham Institute for Medical Research An inhibitor of anti-apoptotic proteins
WO2012120054A1 (de) * 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
JP6453224B2 (ja) 2012-11-05 2019-01-16 コミッサリア ア レネルジ アトミック エ オー エネルジス アルテルナティヴスＣｏｍｍｉｓｓａｒｉａｔ Ａ Ｌ‘Ｅｎｅｒｇｉｅ Ａｔｏｍｉｑｕｅ Ｅｔ Ａｕｘ Ｅｎｅｒｇｉｅｓ Ａｌｔｅｒｎａｔｉｖｅｓ インビボで血液がんの幹細胞を排除するため、および血液がんの再発を防ぐための、チロシンキナーゼ阻害剤のような抗がん剤と、好ましくはチアゾリジンジオンであるｓｔａｔ５アンタゴニストとの組み合わせ
EP3209316A2 (en) 2014-10-24 2017-08-30 Bristol-Myers Squibb Company Modified fgf-21 polypeptides and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148801A (en) * 1978-07-03 1979-04-10 American Home Products Corporation 3-[(Chlorophenylsulfonyl)methyl]-1,2,4-oxadiazole-5-carboxylic acid derivatives
JPS5925466U (ja) * 1982-08-10 1984-02-17 安部　義雄 標準貫入試験装置
JPS59107636U (ja) * 1982-12-29 1984-07-20 ナショナル住宅産業株式会社 地耐力測定装置
JPS6095021A (ja) * 1983-10-31 1985-05-28 Natl House Ind Co Ltd 地耐力測定装置
JPH0516270Y2 (zh) * 1986-03-19 1993-04-28
JPH0372937U (zh) * 1989-11-16 1991-07-23

Also Published As

Publication number Publication date
CA2015032A1 (en) 1990-10-21
KR900016174A (ko) 1990-11-12
DD298925A5 (de) 1992-03-19
PT93812A (pt) 1990-11-20
HUT54360A (en) 1991-02-28
JPH02292272A (ja) 1990-12-03
IL94068A0 (en) 1991-01-31
CN1046528A (zh) 1990-10-31
US4897405A (en) 1990-01-30
NO901728D0 (no) 1990-04-19
NO901728L (no) 1990-10-22
ZA903018B (en) 1991-12-24
HU902496D0 (en) 1990-08-28

Similar Documents

Publication Publication Date Title
FI901956A0 (fi) Nya naftalenylalkyl-3h-1,2,3,5 -oxatiadiazol-2-oxider anvaendbara som antihyperglykemiska medel.
FI922277A (fi) Icke-replicerande, medelst rekombinant-teknik framstaellda retrovirala partiklar, vilka anvaendes som antivirala medel och immunogener.
FI893557A0 (fi) Polyestrar, som innehaoller en eterbrygga.
FI903028A0 (fi) Polymerbaserade blandningskompositioner, som innehaoller destrukturerad staerkelse.
FI914319A (fi) Nya karbocykliska adenosinanaloger anvaendbara som immunosupressanter.
FI891449A (fi) Nya 2,3,4-substituerade imidazoler och 3,4,5-substituerade 1,2,4-triazoler, deras framstaellning och anvaendning.
FI894629A (fi) Nya 3,4-diaminokinolin- och -pyridinfoereningar.
FI911606A (fi) Foerfarande foer framstaellning av nya foereningar, som inhiberar trombocytaggregation.
FI903739A0 (fi) Nya 5-substituerade-1,3,4-tiadiazoler, foerfarande foer deras framstaellning och deras anvaendning som bekaempningsmedel mot skadeinsekter.
FI894798A0 (fi) Nya 1,4-bensoxazin- och 1,4-bensotiazinderivat och foerfarande foer deras framstaellning.
FI905020A0 (fi) Orala kompositioner, som innehaoller monoperoxisyror.
FI894491A0 (fi) Nya substituerade tienopyraner, vilka aer anvaendbara som antihypertensiva medel.
FI872827A0 (fi) Anvaendning av karbocykliskt och heterocykliskt kondenserade dihydropyridiner som kardioskyddande medel och nya heterocykliskt och karbocykliskt kondenserade dihydropyridiner, foerfarande foer deras framstaellning och mellanprodukter.
FI892207A0 (fi) 2-adamantyl-4-isotiazolin-3-oner, deras tillverkningsfoerfarande och anvaendning som baktericida och fungicida medel.
FI904191A0 (fi) Nya aminopropanolderivater, foerfarande foer tillverkning av dessa samt farmaceutiska sammansaettningar som innehaoller dessa.
FI892897A (fi) Nya kondenserade diazepinoner, foerfarande foer deras framstaellning och laekemedel som innehaoller dessa foereningar.
FI900661A0 (fi) Nya formbara sammansaettningar som haerdas i vaerme.
FI901955A0 (fi) Nya naftalenyl-3h-1,2,3,5-oxatiadiazol -2-oxider anvaendbara som, antihyperglykemiska medel.
FI892896A (fi) Nya kondenserade diazepinoner, foerfarande foer deras framstaellning och laekemedel som innehaoller dessa foereningar.
FI906269A (fi) 2,19-metylenoxi- och 2,19-metylentio -tvaerbundna steroider som aromatas- och 19-hydroxylasinhibitorer.
FI895899A0 (fi) Nya trombolytiska proteiner, foerfarande foer deras framstaellning och dessa som aktivaemne innehaollande laekemedel.
FI902902A0 (fi) Foerfarande foer framstaellning av flexibelt polyuretanskum medelst anvaendning av 1,1,1-trikloretan som skumaemne.
FI883735A (fi) Framstaellning av antigener av maenniskans immunbristsjukdom, typ 1, och deras anvaendning som diagnostiska och terapeutiska medel.
FI894256A0 (fi) Ur vaextmaterial framstaellt faergaemne av livsmedelskvalitet, foerfarande foer framstaellning av detsamma och laeskedryck som innehaoller detsamma.
FI884578A (fi) Nya antracyklinderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: AMERICAN HOME PRODUCTS CORPORATION